As lactase replacement acts locally in the gut, there are no reported systemic side effects
Discovery of eryptosis fueled an interest in the investigation of the cell death signaling network in erythrocytes, resulting in the discovery of a regulated necrosis of erythrocytes [25]
In terms of safety and tolerability, the adverse events were primarily mild to moderate gastrointestinal reactions, with no reports of severe hypoglycemia or death
Importantly, such studies have not detected selenenic acid so far during the GPx cycle
Then again, allowing American companies to sell BPC-157 for human use could create the impression that the peptide, which hasnt passed through the rigorous process the FDA uses to approve new drugs, nonetheless has the agencys blessing
Long-acting ones seem to slow stomach emptying less as time goes on [2]